Immunovant ($IMVT) Insider Trading & Smart Money Activity
Immunovant, Inc. ($IMVT) has 16 insider trades, 2 13F position changes and 1 analyst rating on file. In the last 12 months on the open market, no insider bought and 7 insiders sold ($2.82M), net -$2.82M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 7
- Net insider $ (12 mo)
- -$2.82M
- Congress trades (12 mo)
- 0
- 13F moves on file
- 2
- Analyst ratings on file
- 1
IMVT insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 4 · $2.36M | 0 / 0 | 2 / 0 |
| Q3 2026 | 0 | 1 · $103.48K | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 4 · $356.10K | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All IMVT insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Van Tuyl ChristopherChief Legal Officer | Sell (Open-market sale) | 1.33K sh | $42.54K | -12.9% | — | |||||
| Insider | Stout Jay SChief Technology Officer | Sell (Open-market sale) | 3.81K sh | $122.12K | -12.9% | — | |||||
| Insider | Gloria MelanieChief Operating Officer | Sell (Open-market sale) | 2.24K sh | $71.85K | -12.9% | — | |||||
| Insider | Venker EricChief Executive Officer | Sell (Open-market sale) | 3.51K sh | $119.59K | -9.4% | — | |||||
| Insider | Van Tuyl ChristopherChief Legal Officer | Sell (Open-market sale) | 2.85K sh | $103.48K | -2.2% | — | |||||
| Analyst | Citigroup | Reiterates to buy | PT $61 | +4.0% | +2.5% | Read | |||||
| Insider | Van Tuyl ChristopherChief Legal Officer | Sell (Option exercise) | 17.82K sh | -0.6% | +3.2% | — | |||||
| Insider | Van Tuyl ChristopherChief Legal Officer | Buy (Option exercise) | 17.82K sh | $270.92K | -0.6% | +3.2% | — | ||||
| Insider | Jay StoutChief Technology Officer | Sell (Open-market sale) | 40K sh | $1.53M | -0.6% | +3.2% | — | ||||
| Insider | Atul Pande | Sell (Open-market sale) 10b5-1 | 1.50K sh | $57.02K | -0.6% | +3.2% | — | ||||
| Insider | Atul Pande | Buy (Option exercise) | 1.50K sh | $12.64K | -0.6% | +3.2% | — | ||||
| Insider | Melanie GloriaChief Operating Officer | Sell (Open-market sale) | 17.71K sh | $678.60K | -0.6% | +3.2% | — | ||||
| Insider | Tiago GiraoChief Financial Officer | Sell (Option exercise) | 10K sh | -0.6% | +3.2% | — | |||||
| Insider | Tiago GiraoChief Financial Officer | Buy (Option exercise) | 10K sh | $159K | -0.6% | +3.2% | — | ||||
| Insider | Van Tuyl ChristopherChief Legal Officer | Sell (Open-market sale) | 2.63K sh | $93.22K | +8.2% | +13.0% | Read | ||||
| Insider | Atul Pande | Sell (Option exercise) | 1.50K sh | +13.9% | +19.3% | — | |||||
| Insider | Atul Pande | Buy (Option exercise) | 1.50K sh | $12.64K | +13.9% | +19.3% | — | ||||
| 13F | Farallon Capital Management | Added | +1.53M sh | $51.98M | +24.2% | +21.6% | — | ||||
| 13F | Farallon Capital Management | Added | +1.53M sh | $59.57M | +24.2% | +21.6% | Read |
1W / 1M / 6M = how IMVT moved from the trade or filing date.
Insider trading in IMVT: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Van Tuyl Christopher | Chief Legal Officer | 5 | -$239.24K | Oct 7, 2026 | |
| Stout Jay S | Chief Technology Officer | 1 | -$122.12K | Oct 7, 2026 | |
| Gloria Melanie | Chief Operating Officer | 1 | -$71.85K | Oct 7, 2026 | |
| Venker Eric | Chief Executive Officer | 1 | -$119.59K | Oct 2, 2026 | |
| Atul Pande | 4 | -$57.02K | Jun 26, 2026 | ||
| Tiago Girao | Chief Financial Officer | 2 | — | Jun 26, 2026 | |
| Jay Stout | Chief Technology Officer | 1 | -$1.53M | Jun 26, 2026 | |
| Melanie Gloria | Chief Operating Officer | 1 | -$678.60K | Jun 26, 2026 |
Institutions moving IMVT (13F)
Analyst ratings on IMVT
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Citigroup | Reiterates | buy | $61 | +4.0% | +2.5% | Read |
Frequently asked questions
Are IMVT insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 7 insiders made 9 open-market sales worth $2.82M, a net -$2.82M.
What is the latest insider trade in IMVT?
Van Tuyl Christopher, Chief Legal Officer filed a sell (open-market sale) of 1.33K sh worth $42.54K on Oct 7, 2026.
Which institutions changed their IMVT positions?
Recent 13F filers moving the stock include Farallon Capital Management.
Other biotechnology stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.